G
Genixus develops targeted pharmaceutical formulations for acute and critical care, focusing on enhancing the efficacy and safety of life-saving medications. The company addresses the urgent need for improved treatment options in high-stakes medical environments, ensuring better patient outcomes and streamlined care processes.
Updated 4 months ago
Funding
$20M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Genixus develops targeted pharmaceutical formulations for acute and critical care, focusing on enhancing the efficacy and safety of life-saving medications. The company addresses the urgent need for improved treatment options in high-stakes medical environments, ensuring better patient outcomes and streamlined care processes.